GW PharmaceuticalsGWPH
13F holders, Q2 2024 (June 30)1holders
$216.89avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding GW Pharmaceuticals Ltd. (GWPH) in their 13F filings. The largest holder was Strategic Investment Solutions, Inc. ($8K).
- Company
- GW Pharmaceuticals Ltd.
- CUSIP
- 36197T103
- Latest filing quarter
- Q2 2024
Total Exit/New Position Q2 2024
No earlier quarter to compare with.
Ownership 1 holders
| Strategic Investment Solutions, Inc. | 0.00% | — | 38 | $8K |
"% of holder's portfolio" is GWPH's weight in each manager's 13F, not the share of GW Pharmaceuticals Ltd. the manager owns.